US53216B1044 - Common Stock
LIFEMD INC
NASDAQ:LFMD (5/8/2024, 4:31:23 PM)
After market: 10.9 -1.43 (-11.6%)12.33
-0.05 (-0.4%)
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 199 full-time employees. The company went IPO on 2001-07-11. The firm has two segments: Telehealth and WorkSimpli. Telehealth segment is engaged in telehealth platform, which integrates a clinician-centric electronic medical record system, algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. Its technology platform, combined with its 50-state affiliated provider network, enables the management of virtual treatment offerings and complex patient journeys for hundreds of conditions spanning men’s and women’s health, dermatology, urgent, and primary care, chronic care management and other. WorkSimpli segment operates PDFSimpli, which is an online software as a service platform that allows users to create, edit, convert, sign and share PDF documents.
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022
P: 18663515907
CEO: Justin Schreiber
Employees: 199
Website: https://lifemd.com/
Stay updated with the stocks that are on the move in today's after-hours session.
First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period.Raising full-year...
/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating LifeMD, Inc. (NASDAQ: LFMD) on behalf of the company's shareholders. The...
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve...
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.
Here you can normally see the latest stock twits on LFMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: